Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Chronic Lymphocytic Leukemia

Known as: Chronic B-Lymphocytic Leukemias, B-Cell Leukemias, Chronic, Lymphoma, CLL Lymphoplasmacytoid 
A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Regulatory T cells (Tregs) are important for the induction and maintenance of peripheral tolerance therefore, they are key in… Expand
  • figure 1
  • table 1
  • table 2
Review
2019
Review
2019
Stem cell therapy is being intensely investigated within the last years. Expectations are high regarding mesenchymal stem cell… Expand
  • figure 1
Review
2019
Review
2019
Therapeutic monoclonal antibodies targeting immune checkpoints (ICPs) have changed the treatment landscape of many tumors… Expand
  • figure 1
  • figure 2
  • table 1
Review
2019
Review
2019
The European Society of Cardiology (ESC) has published a series of guidelines on heart failure (HF) over the last 25 years, most… Expand
Review
2019
Review
2019
Effective adoptive T cell therapy (ACT) comprises the killing of cancer cells through the therapeutic use of transferred T cells… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Review
2019
Review
2019
The development of immunotherapies over the past decade has resulted in a paradigm shift in the treatment of cancer. However, the… Expand
  • figure 1
  • table 1
  • table 1
  • figure 2
  • figure 3
Review
2019
Review
2019
Chronic wounds are a health problem that have devastating consequences for patients and contribute major costs to healthcare… Expand
Review
2019
Review
2019
B cells and the antibodies they produce have a deeply penetrating influence on human physiology. Here, we review current… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Review
2019
Review
2019
The two thrombopoietin receptor agonists (TPO-RA), eltrombopag and romiplostim, were licensed in the US for treatment of immune… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Review
2018
Review
2018
The current landscape of therapeutics designed to treat multiple sclerosis (MS) and its pathological sequelae is saturated with… Expand
  • figure 1
  • figure 2
  • figure 3